Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Jul 31, 2023

BUY
$126.43 - $145.6 $34,136 - $39,312
270 New
270 $39.3 Million
Q4 2022

Feb 16, 2023

BUY
$104.7 - $128.4 $10,365 - $12,711
99 Added 4.73%
2,190 $278 Million
Q1 2022

May 03, 2022

BUY
$108.42 - $129.58 $325 - $388
3 Added 0.14%
2,091 $252,000
Q4 2021

Feb 01, 2022

BUY
$115.43 - $146.63 $346 - $439
3 Added 0.14%
2,088 $257,000
Q3 2021

Dec 09, 2021

SELL
$136.35 - $158.76 $1,636 - $1,905
-12 Reduced 0.57%
2,085 $296,000
Q2 2021

Aug 19, 2021

SELL
$152.95 - $173.41 $3,517 - $3,988
-23 Reduced 1.08%
2,097 $306,000
Q1 2021

May 11, 2021

SELL
$148.16 - $159.71 $9,482 - $10,221
-64 Reduced 2.93%
2,120 $367,000
Q4 2020

Feb 09, 2021

BUY
$128.25 - $151.41 $256 - $302
2 Added 0.09%
2,184 $351,000
Q3 2020

Dec 18, 2020

BUY
$113.59 - $141.68 $340 - $425
3 Added 0.14%
2,182 $324,000
Q2 2020

Aug 19, 2020

BUY
$87.02 - $133.4 $261 - $400
3 Added 0.14%
2,179 $301,000
Q1 2020

May 15, 2020

SELL
$78.28 - $155.73 $7,749 - $15,417
-99 Reduced 4.35%
2,176 $244,000
Q4 2019

Feb 14, 2020

BUY
$127.4 - $146.83 $28,028 - $32,302
220 Added 10.71%
2,275 $361,000
Q3 2019

Nov 15, 2019

BUY
$113.33 - $138.46 $339 - $415
3 Added 0.15%
2,055 $297,000
Q2 2019

Aug 19, 2019

BUY
$108.87 - $125.09 $14,588 - $16,762
134 Added 6.99%
2,052 $284,000
Q1 2019

May 16, 2019

SELL
$97.5 - $125.79 $1,657 - $2,138
-17 Reduced 0.88%
1,918 $227,000
Q4 2018

Feb 20, 2019

BUY
$94.4 - $126.76 $2,171 - $2,915
23 Added 1.2%
1,935 $239,000
Q3 2018

Nov 21, 2018

BUY
$108.41 - $127.64 $650 - $765
6 Added 0.31%
1,912 $215,000
Q2 2018

Aug 16, 2018

BUY
$102.12 - $114.04 $306 - $342
3 Added 0.16%
1,906 $212,000
Q1 2018

May 16, 2018

BUY
$104.31 - $124.46 $198,501 - $236,847
1,903 New
1,903 $207,000

Others Institutions Holding ZBH

About ZIMMER BIOMET HOLDINGS, INC.


  • Ticker ZBH
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 209,820,000
  • Market Cap $23.3B
  • Description
  • Zimmer Biomet Holdings, Inc., together with its subsidiaries, operates in the musculoskeletal healthcare business in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company designs, manufactures, and markets orthopaedic reconstructive products, such as knee and hip products; S.E.T. products, including sports medicine, bi...
More about ZBH
Track This Portfolio

Track Wealth Plan Partners, LLC Portfolio

Follow Wealth Plan Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wealth Plan Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wealth Plan Partners, LLC with notifications on news.